With the news from Saperta, I was wondering how this effects Prosensa/GSK? With all the trial information they have, why have they not tried for accelerated approval? Anyone have any thoughts or opinions on this, seems to me the first one to get 51 approved wins.
You can share this discussion in two ways…
Share this link:
Send it with your computer's email program: Email this